 
    Dr. Salvatore Brugaletta
Médico Cardiólogo, HCB. Miembro del CEAResearch group
- Atherosclerosis, coronary disease and heart failure Accredited researcher (R3A)
Featured publications
- 
                    Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover StudyAuthors:Reference: Jacc-Cardiovascular Interventions 2018.
- 
                    Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trialAuthors:Reference: Lancet 2018.
- 
                    Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold ThrombosisAuthors:Reference: Jacc-Cardiovascular Interventions 2017.
- 
                    Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.Authors:Reference: Eurointervention 2017.
- 
                    Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCIAuthors:Reference: New England Journal Of Medicine 2017.
- 
                    Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trialAuthors:Reference: Lancet 2016.
- 
                    Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trialAuthors:Reference: European Heart Journal 2016.
- 
                    Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic FindingsAuthors:Reference: Journal Of The American College Of Cardiology 2015.
- 
                    Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-Year results of a propensity score matching comparison: the BVS-examination study (Bioresorbable Vascular Scaffold-a clinicalAuthors:Reference: Jacc-Cardiovascular Interventions 2015.
- 
                    The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trialAuthors:Reference: Jacc-Cardiovascular Interventions 2014.
